Stage IIIB Breast Cancer Completed Phase 1 / 2 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00258349Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast CancerTreatment